These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36969352)

  • 1.
    Ibrahim A; Chattaraj A; Iqbal Q; Anjum A; Rehman MEU; Aijaz Z; Nasir F; Ansar S; Zangeneh TT; Iftikhar A
    Avicenna J Med; 2023 Jan; 13(1):23-34. PubMed ID: 36969352
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii: a review with a focus on prevention and treatment.
    Weyant RB; Kabbani D; Doucette K; Lau C; Cervera C
    Expert Opin Pharmacother; 2021 Aug; 22(12):1579-1592. PubMed ID: 33870843
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
    Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
    Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
    Helweg-Larsen J; Benfield T; Atzori C; Miller RF
    J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.
    Ghembaza A; Vautier M; Cacoub P; Pourcher V; Saadoun D
    Chest; 2020 Dec; 158(6):2323-2332. PubMed ID: 32502592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
    Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
    Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
    Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
    Liebling M; Rubio E; Ie S
    Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3.
    Sidhu VK; Foisy MM; Hughes CA
    Ann Pharmacother; 2015 Dec; 49(12):1343-8. PubMed ID: 26358129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical descriptive analysis of severe
    Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
    Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease-a Case Series.
    Vieujean S; Moens A; Hassid D; Rothfuss K; Savarino EV; Vavricka SR; Reenaers C; Jacobsen BA; Allez M; Ferrante M; Rahier JF
    J Crohns Colitis; 2023 Apr; 17(4):472-479. PubMed ID: 36223253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fact or fiction: does the non-HIV/AIDS immunosuppressed patient need Pneumocystis jiroveci pneumonia prophylaxis? An updated literature review.
    Grewal P; Brassard A
    J Cutan Med Surg; 2009; 13(6):308-12. PubMed ID: 19919808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids.
    Basiaga ML; Ross ME; Gerber JS; Ogdie A
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):283-289. PubMed ID: 28992298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.